This report studies the global in vitro fertilization market for the forecast period of 2016 to 2021. This market is expected to reach USD 756.7 Million by 2021 from USD 468.3 Million in 2016, at a CAGR of 10.1%.
Browse 100 market data Tables and 41 Figures spread through 159 Pages and in-depth TOC on “In Vitro Fertilization Market”
The In Vitro Fertilization Market analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape, and geographical markets.
Growth in the global in vitro fertilization market is mainly driven by declining fertility rates, growth in the media age of first-time motherhood, growing cases of male infertility, growth in healthcare expenditure, rise in consumption of alcohol and cigarettes, implementation of government initiatives and introduction of new and advanced products.
The global in vitro fertilization market is segmented on the basis of technology, product, end user, and region. By technology, the in vitro fertilization market is categorized into intra-cytoplasmic sperm injection, pre-implantation genetic diagnosis, frozen embryo transplantation and others (assisted hatching, intrauterine insemination, donor insemination and in vitro maturation).
On the basis of product, the market is segmented into reagents and equipment. Reagent is further categorized into cryopreservation media, sperm processing media, ovum processing media and embryo culture media.
Equipment is further categorized into incubators, imaging systems, cabinets (workstation), ovum aspiration pump, sperm separation systems, micromanipulator systems, cryosystems, gas analyzers, laser systems, anti-vibration table and accessories.
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific accounted for the largest share of the in vitro fertilization market in 2016, followed by Europe and North America.
The large share of the Asia-Pacific in vitro fertilization market can primarily be attributed to the high maternal age in Japan, abolishment of China’s one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand. In addition, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period.
Some of the key players in the health information exchange market are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ESCO Micro Pte. Limited (Singapore), Genea Limited (Australia), The Baker Company (U.S.), IVFtech ApS (Denmark) and EMD Serono, Inc. (U.S.).